029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
RLN1041肺癌及正常组织组合芯片,附病理分级、TNM、临床分期,104例/104点
点 数104例 数104
行 数8列 数13
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:RLN1041
 
肺癌及正常组织组合微阵列芯片,包含52例鳞状细胞癌,15例腺癌,10例细支气管肺泡癌,7例腺磷癌,5例大细胞癌,2例不典型类癌,3例小细胞癌,3例神经内分泌癌,3例结核,4例肺组织,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Inflammation (*)
 
Malignant (*)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Normal (*)
TISSUE  ARRAYS RLN1041
1
2
3
4
5
6
7
8
9
10
11
12
13
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1153MLungSquamous cell carcinoma1T2N0M0IBMalignant3*3*3N
A2250MLungSquamous cell carcinoma1T3N1M0IIIAMalignant*N
A3324MLungSquamous cell carcinoma1T2aN0M0IBMalignant*N
A4468MLungSquamous cell carcinoma1T2N0M0IBMalignant*N
A5530MLungSquamous cell carcinoma1--2T2N0M0IBMalignant4.5*4*3N
A6650MLungSquamous cell carcinoma with necrosis (sparse)1--2T2N0M0IBMalignant7.5*5*4N
A7764MLungSquamous cell carcinoma1--2T2N0M0IBMalignant*N
A8864MLungSquamous cell carcinoma2T2N0M0IBMalignant5*4*4N
A9969MLungSquamous cell carcinoma with necrosis2T2N2M0IIIAMalignant*N
A101060MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
A111168MLungSquamous cell carcinoma with necrosis2T2N2M0IIIAMalignant*N
A121245MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
A131361MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
B11460FLungSquamous cell carcinoma2T2N1M0IIBMalignant5*4*4N
B21558MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
B31661MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B41748MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
B51852FLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B61972MLungSquamous cell carcinoma2T2N0M0IBMalignant4*3*3N
B72030MLungSquamous cell carcinoma2T2N0M0IBMalignant5*3*3N
B82158MLungSquamous cell carcinoma2T3N1N0IIIAMalignant4*4*3N
B92259MLungSquamous cell carcinoma2T2bN0N0IIAMalignant*N
B102364MLungSquamous cell carcinoma2T2N2M0IIIAMalignant*N
B112459MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
B122547MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
B132649FLungSquamous cell carcinoma2T2N0M0IBMalignant*N
C12757MLungSquamous cell carcinoma2T2N0M0IBMalignant8*8*7N
C22870MLungSquamous cell carcinoma2T3N0M0IIBMalignant5*4*4N
C32955MLungSquamous cell carcinoma2T4N1M0IIIAMalignant3*2*1.5N
C43056MLungSquamous cell carcinoma2T3N0M0IIBMalignant6.5*5*5N
C53167MLungSquamous cell carcinoma2T2bN0N0IIAMalignant4*3.5*3N
C63269MLungSquamous cell carcinoma2T2N1M0IIBMalignant7*5*4N
C73355MLungSquamous cell carcinoma with necrosis2T2bN0N0IIAMalignant5.5*4*3.5N
C83455MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
C93567MLungSquamous cell carcinoma with necrosis2T2bN1M0IIBMalignant7*6*6N
C103663MLungSquamous cell carcinoma2T2N0M0IBMalignant3*2*1.5N
C113775MLungSquamous cell carcinoma2T3N0M0IIBMalignant*N
C123869MLungSquamous cell carcinoma2T2N1M0IIBMalignant4*4*3N
C133953FLungSquamous cell carcinoma2T2N0M0IBMalignant*N
D14056MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
D24166MLungSquamous cell carcinoma2--3T2bN0M0IIAMalignant4.0*4.0*2.5N
D34250FLungSquamous cell carcinoma with necrosis2--3T2aN0M0IBMalignant*N
D44356MLungSquamous cell carcinoma3T2aN2M0IIIAMalignant*N
D54465MLungSquamous cell carcinoma3T2N1M0IIBMalignant5*4*3.5N
D64567MLungSquamous cell carcinoma3T1N0M0IAMalignant*N
D74660MLungSquamous cell carcinoma with necrosis3T2bN0N0IIAMalignant6*5*5N
D84759MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
D94863MLungSquamous cell carcinoma3T3N1M0IIIAMalignant*N
D104962MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
D115064FLungSquamous cell carcinoma3T2N0M0IBMalignant*N
D125146FLungSquamous cell carcinoma3T2N0M0IBMalignant*N
D135271MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
E15372MLungAdenocarcinoma1T3N0M0IIBMalignant6.0N
E25449FLungAdenocarcinoma with necrosis1--2T2N0M0IBMalignant*N
E35563FLungAdenocarcinoma1--2T2bN0N0IIAMalignant*N
E45670MLungAdenocarcinoma2T3N1M0IIIAMalignant7.0N
E55743FLungAdenocarcinoma2T2N0M0IBMalignant3.5*3*2.5N
E65837FLungAdenocarcinoma with necrosis2T2N0M0IBMalignant*N
E75942MLungAdenocarcinoma2T2N0M0IBMalignant*N
E86059MLungAdenocarcinoma2T2aN0M0IBMalignant*N
E96148MLungAdenocarcinoma2T2N1M0IIBMalignant*N
E106262MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3N
E116365MLungAdenocarcinoma2T2bN0N0IIAMalignant7.5*5.0*4N
E126448MLungAdenocarcinoma3T2aN0M0IBMalignant*N
E136570MLungAdenocarcinoma3T2N0M0IBMalignant6.5*4.5*4N
F166F74LungBronchioloalveolar carcinoma***Malignant*N
F267M58LungBronchioloalveolar carcinoma***Malignant*N
F368M74LungBronchioloalveolar carcinoma***Malignant*N
F469F56LungBronchioloalveolar carcinoma***Malignant*N
F570F74LungBronchioloalveolar carcinoma***Malignant*N
F671F55LungBronchioloalveolar carcinoma***Malignant*N
F772M49LungBronchioloalveolar carcinoma***Malignant*N
F873M50LungBronchioloalveolar carcinoma***Malignant*N
F974M51LungBronchioloalveolar carcinoma***Malignant*N
F1075F56LungBronchioloalveolar carcinoma***Malignant*N
F1176F58LungAdenosquamous carcinoma*T2bN1M0IIBMalignant6.5*5.0*4.5N
F1277F55LungAdenosquamous carcinoma*T2N1M0IIBMalignant*N
F1378M65LungAdenocarcinoma*T2N0M0IBMalignant*N
G179M50LungAdenosquamous carcinoma*T2N1M0IIBMalignant*N
G280M46LungAdenosquamous carcinoma*T2N0M0IBMalignant*N
G381F63LungAdenosquamous carcinoma*T2N0M0IBMalignant*N
G482M68LungAdenosquamous carcinoma*T2N0M0IBMalignant*N
G583M64LungAdenosquamous carcinoma*T2aN0M0IBMalignant*N
G684F65LungAdenocarcinoma*T2bN2M0IIIAMalignant*N
G785M64LungLarge cell carcinoma***Malignant*N
G886M60LungLarge cell carcinoma***Malignant*N
G987M60LungLarge cell carcinoma***Malignant*N
G1088M69LungLarge cell carcinoma with necrosis***Malignant*N
G1189F60LungLarge cell carcinoma (sparse)***Malignant*N
G129036FLungAtypical carcinoid*T2aN0M0IBMalignant*N
G139149MLungAtypical carcinoid*T4N2M0IIIBMalignant*N
H19252MLungSmall cell carcinoma with necrosis*T2aN0M0IBMalignant4.0N
H29361MLungSmall cell carcinoma*T2N0M0IBMalignant3.5*3*0.7N
H39452MLungSmall cell carcinoma***Malignant4*5N
H49563MLungNeuroendocrine carcinoma***Malignant*N
H59682MLungNeuroendocrine carcinoma with necrosis***Malignant*N
H69753MLungNeuroendocrine carcinoma***Malignant*N
H79854MLungPulmonary tuberculosis***Inflammation*N
H89963FLungPulmonary tuberculosis (necrosis)***Inflammation*N
H910050FLungPulmonary tuberculosis***Inflammation*N
H1010125FLungLung tissue***Normal*N
H1110219MLungLung tissue***Normal*N
H1210340FLungLung tissue***Normal*N
H1310447MLungLung tissue***Normal*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情